Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Maze Therapeutics Inc (MAZE)

Maze Therapeutics Inc (MAZE)
3.86 x 2 10.30 x 8
Post-market by (Cboe BZX)
9.90 -1.11 (-10.08%) 04/01/25 [NASDAQ]
3.86 x 2 10.30 x 8
Post-market 10.30 +0.40 (+4.04%) 16:09 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.50
Day High
10.78
Open 10.70
Previous Close 11.01 11.01
Volume 1,048,700 1,048,700
Avg Vol 317,375 317,375
Stochastic %K 32.38% 32.38%
Weighted Alpha N/A N/A
5-Day Change -1.73 (-14.88%) -1.73 (-14.88%)
52-Week Range 9.49 - 17.00 9.49 - 17.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 481,985
  • Shares Outstanding, K 43,777
  • Annual Sales, $ 0 K
  • Annual Income, $ -100,415 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 2.59
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on 01/31/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.60
  • Number of Estimates 2
  • High Estimate -0.58
  • Low Estimate -0.62
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.49 +4.27%
on 04/01/25
Period Open: 12.23
13.04 -24.08%
on 03/07/25
-2.33 (-19.05%)
since 02/28/25

Business Summary

Maze Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases. Maze Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif....

See More

Key Turning Points

3rd Resistance Point 11.90
2nd Resistance Point 11.34
1st Resistance Point 10.62
Last Price 9.90
1st Support Level 9.34
2nd Support Level 8.78
3rd Support Level 8.06

See More

52-Week High 17.00
Fibonacci 61.8% 14.13
Fibonacci 50% 13.25
Fibonacci 38.2% 12.36
Last Price 9.90
52-Week Low 9.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies